Autophagy, warburg, and warburg reverse effects in human cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Gonzalez, Claudio D ^a,b   Alvarez, Silvia ^a   Ropolo, Alejandro ^a   Rosenzvit, Carla ^b   Gonzalez Bagnes, Maria F ^b   Vaccaro, Maria I ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b CEMIC   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANAEROBIC GLYCOLYSIS; AUTOPHAGY; CANCER GROWTH; CARCINOGENESIS; CELL ENERGY; CELL METABOLISM; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; FIBROBLAST; GLUCOSE METABOLISM; HUMAN; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; WARBURG EFFCT; WARBURG REVERSE EFFECT; BIOLOGICAL MODEL; GLYCOLYSIS; METABOLISM; NEOPLASM; PATHOLOGY;

AUTOPHAGY; GLYCOLYSIS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 84907380852     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/926729     Document Type: Review

References (99)

1. A. M. Cuervo, "Autophagy: in sickness and in health," Trends in Cell Biology, vol. 14, no. 2, pp. 70-77, 2004.
2. B. Levine and D. J. Klionsky, "Development by self-digestion: molecular mechanisms and biological functions of autophagy," Developmental Cell, vol. 6, no. 4, pp. 463-477, 2004.
3. Z. Yang and D. J. Klionsky, "An overview of the molecular mechanism of autophagy," Current Topics in Microbiology and Immunology, vol. 335, no. 1, pp. 1-32, 2009.
4. A. S. Vincent, T. T. Phan, A. Mukhopadhyay, H. Y. Lim, B. Halliwell, and K. P. Wong, "Human skin keloid fibroblasts display bioenergetics of cancer cells," Journal of Investigative Dermatology, vol. 128, no. 3, pp. 702-709, 2008.
5. S. Pavlides, D. Whitaker-Menezes, R. Castello-Cros et al., "The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma," Cell Cycle, vol. 8, no. 23, pp. 3984-4001, 2009.
6. T. Hara, K. Nakamura, M. Matsui et al., "Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice," Nature, vol. 441, no. 7095, pp. 885-889, 2006.
7. X. Qu, Z. Zou, Q. Sun et al., "Autophagy gene-dependent clearance of apoptotic cells during embryonic development," Cell, vol. 128, no. 5, pp. 931-946, 2007.
8. S. Pattingre and B. Levine, "Bcl-2 inhibition of autophagy: a new route to cancer?" Cancer Research, vol. 66, no. 6, pp. 2885-2888, 2006.
9. T. Shintani and D. J. Klionsky, "Autophagy in health and disease: a double-edged sword," Science, vol. 306, no. 5698, pp. 990-995, 2004.
10. D. J. Klionsky, "Autophagy," Current Biology, vol. 15, no. 8, pp. 282-283, 2005.
11. D. J. Klionsky and S. D. Emr, "Autophagy as a regulated pathway of cellular degradation," Science, vol. 290, no. 5497, pp. 1717-1721, 2000.
12. N. Mizushima, "The pleiotropic role of autophagy: from protein metabolism to bactericide," Cell Death & Differentiation, vol. 12, no. 2, pp. 1535-1541, 2005.
13. D. J. Klionsky, J. M. Cregg, W. A. Dunn Jr. et al., "A unified nomenclature for yeast autophagy-related genes," Developmental Cell, vol. 5, no. 4, pp. 539-545, 2003.
14. X. H. Liang, S. Jackson, M. Seaman et al., "Induction of autophagy and inhibition of tumorigenesis by beclin 1," Nature, vol. 402, no. 6762, pp. 672-676, 1999.
15. S. Pattingre, A. Tassa, X. Qu et al., "Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy," Cell, vol. 122, no. 6, pp. 927-939, 2005.
16. C. Liang, P. Feng, B. Ku et al., "Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG," Nature Cell Biology, vol. 8, no. 7, pp. 688-698, 2006.
17. A. Kihara, T. Noda, N. Ishihara, and Y. Ohsumi, "Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase y sorting in Saccharomyces cerevisiae," Journal of Cell Biology, vol. 153, no. 3, pp. 519-530, 2001.
18. C. He and D. J. Klionsky, "Regulation mechanisms and signaling pathways of autophagy," Annual Review of Genetics, vol. 43, pp. 67-93, 2009.
19. E. Itakura and N. Mizushima, "Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins," Autophagy, vol. 6, no. 6, pp. 764-776, 2010.
20. M. I. Vaccaro, A. Ropolo, D. Grasso, and J. L. Iovanna, "A novel mammalian trans-membrane protein reveals an alternative initiation pathway for autophagy," Autophagy, vol. 4, no. 3, pp. 388-390, 2008.
21. Z. Yang and D. J. Klionsky, "Mammalian autophagy: core molecular machinery and signaling regulation," Current Opinion in Cell Biology, vol. 22, no. 2, pp. 124-131, 2010.
22. M. Høyer-Hansen and M. Jäättelä, "AMP-activated protein kinase: a universal regulator of autophagy?" Autophagy, vol. 3, pp. 381-383, 2007.
23. M. Zheng, Y. Wang, X. Wu et al., "Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1," Nature Cell Biology, vol. 13, no. 3, pp. 263-272, 2011.
24. T. Nobukuni, M. Joaquin, M. Roccio et al., "Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 40, pp. 14238-14243, 2005.
25. S. Wullschleger, R. Loewith, and M. N. Hall, "TOR signaling in growth and metabolism," Cell, vol. 124, no. 3, pp. 471-484, 2006.
26. Y. Sancak, L. Bar-Peled, R. Zoncu, A. L. Markhard, S. Nada, and D. M. Sabatini, "Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids," Cell, vol. 141, no. 2, pp. 290-303, 2010.
27. D. M. Gwinn, D. B. Shackelford, D. F. Egan et al., "AMPK phosphorylation of raptor mediates a metabolic checkpoint," Molecular Cell, vol. 30, no. 2, pp. 214-226, 2008.
28. B. Levine, S. Sinha, and G. Kroemer, "Bcl-2 family members: dual regulators of apoptosis and autophagy," Autophagy, vol. 4, no. 5, pp. 600-606, 2008.
29. J. Botti, M. Djavaheri-Mergny, Y. Pilatte, and P. Codogno, "Autophagy signaling and the cogwheels of cancer," Autophagy, vol. 2, no. 2, pp. 67-73, 2006.
30. D. R. Green and R. Wang, "Calcium and energy: making the cake and eating it too?" Cell, vol. 142, no. 2, pp. 200-202, 2010.
31. K. Tracy, B. C. Dibling, B. T. Spike, J. R. Knabb, P. Schumacker, and K. F. Macleod, "BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy," Molecular and Cellular Biology, vol. 27, no. 17, pp. 6229-6242, 2007.
32. C. J. Sherr, "Autophagy by ARF: a Short Story," Molecular Cell, vol. 22, no. 4, pp. 436-437, 2006.
33. D. Crighton, S. Wilkinson, and K. M. Ryan, "DRAM links autophagy to p53 and programmed cell death," Autophagy, vol. 3, no. 1, pp. 72-74, 2007.
34. H. G. Xia, L. Zhang, G. Chen et al., "Control of basal autophagy by calpain1 mediated cleavage of ATG5," Autophagy, vol. 6, no. 1, pp. 61-66, 2010.
35. K. R. Mills, M. Reginato, J. Debnath, B. Queenan, and J. S. Brugge, "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3438-3443, 2004.
36. J. O. Pyo, M. H. Jang, Y. K. Kwon et al., "Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death," The Journal of Biological Chemistry, vol. 280, no. 21, pp. 20722-20729, 2005.
37. S. Sarkar and D. C. Rubinsztein, "Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations," Autophagy, vol. 2, no. 2, pp. 132-134, 2006.
38. S. Sarkar, E. O. Perlstein, S. Imarisio et al., "Small molecules enhance autophagy and reduce toxicity in Huntington's disease models," Nature Chemical Biology, vol. 3, no. 6, pp. 331-338, 2007.
39. N. Mizushima, "The role of the Atg1/ULK1 complex in autophagy regulation," Current Opinion in Cell Biology, vol. 22, no. 2, pp. 132-139, 2010.
40. A. Ropolo, D. Grasso, R. Pardo et al., "The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells," Journal of Biological Chemistry, vol. 282, no. 51, pp. 37124-37133, 2007.
41. D. Grasso, A. Ropolo, A. Lo Ré et al., "Zymophagy, a novel selective autophagy pathway mediated by VMP1-USP9x-p62, prevents pancreatic cell death," Journal of Biological Chemistry, vol. 286, no. 10, pp. 8308-8324, 2011.
42. A. E. Lo Ré, M. G. Fernández-Barrena, L. L. Almada et al., "Novel AKT1-GLI3-VMP1 pathway mediates KRAS oncogene-induced autophagy in cancer cells," The Journal of Biological Chemistry, vol. 287, no. 30, pp. 25325-25334, 2012.
43. M. I. Molejon, A. Ropolo, A. L. Re, V. Boggio, and M. I. Vaccaro, "The VMP1-Beclin 1 interaction regulates autophagy induction," Scientific Reports, vol. 3, article 1055, 2013.
44. Y. Tian, Z. Li, W. Hu et al., "C. elegans screen identifies autophagy genes specific to multicellular organisms," Cell, vol. 141, no. 6, pp. 1042-1055, 2010.
45. J. Calvo-Garrido and R. Escalante, "Autophagy dysfunction and ubiquitin-positive protein aggregates in Dictyostelium cells lacking Vmp1," Autophagy, vol. 6, no. 1, pp. 100-109, 2010.
46. R. Pardo, A. Lo Ré, C. Archange et al., "Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells," Pancreatology, vol. 10, no. 1, pp. 19-26, 2010.
47. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, "Autophagy fights disease through cellular self-digestion," Nature, vol. 451, no. 7182, pp. 1069-1075, 2008.
48. M. Høyer-Hansen and M. Jäättelä, "Autophagy: an emerging target for cancer therapy," Autophagy, vol. 4, pp. 574-580, 2008.
49. S. Tóth, K. Nagy, Z. Pálfia, and G. Réz, "Cellular autophagic capacity changes during azaserine-induced tumour progression in the rat pancreas: up-regulation in all premalignant stages and down-regulation with loss of cycloheximide sensitivity of segregation along with malignant transformation," Cell and Tissue Research, vol. 309, no. 3, pp. 409-416, 2002.
50. X. Qu, J. Yu, G. Bhagat et al., "Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene," Journal of Clinical Investigation, vol. 112, no. 12, pp. 1809-1820, 2003.
51. B. Levine, "Cell biology: autophagy and cancer," Nature, vol. 446, pp. 745-747, 2007.
52. R. Mathew, V. Karantza-Wadsworth, and E. White, "Role of autophagy in cancer," Nature Reviews Cancer, vol. 7, no. 12, pp. 961-967, 2007.
53. R. Kiffin, U. Bandyopadhyay, and A. M. Cuervo, "Oxidative stress and autophagy," Antioxidants and Redox Signaling, vol. 8, no. 1-2, pp. 152-162, 2006.
54. D. Tang, R. Kang, K. M. Livesey, H. J. Zeh III, and M. T. Lotze, "High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress," Antioxidants & Redox Signaling, vol. 15, no. 8, pp. 2185-2195, 2011.
55. D. Tang, R. Kang, K. M. Livesey et al., "Endogenous HMGB1 regulates autophagy," Journal of Cell Biology, vol. 190, no. 5, pp. 881-892, 2010.
56. R. Kang, D. Tang, K. M. Livesey, N. E. Schapiro, M. T. Lotze, and H. J. Zeh, "The receptor for advanced glycation end-products (RAGE) protects pancreatic tumor cells against oxidative injury," Antioxidants and Redox Signaling, vol. 15, no. 8, pp. 2175-2184, 2011.
57. J. Du, S. M. Martin, M. Levine et al., "Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer," Clinical Cancer Research, vol. 16, no. 2, pp. 509-520, 2010.
58. M. Donadelli, I. Dando, T. Zaniboni et al., "Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism," Cell Death and Disease, vol. 2, no. 4, article e152, 2011.
59. P. Büchler, H. A. Reber, R. S. Lavey et al., "Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model," Journal of Surgical Research, vol. 120, no. 2, pp. 295-303, 2004.
60. K. Izuishi, K. Kato, T. Ogura, T. Kinoshita, and H. Esumi, "Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy," Cancer Research, vol. 60, no. 21, pp. 6201-6207, 2000.
61. H. Esumi, K. Izuishi, K. Kato et al., "Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5′-AMP-activated protein kinase-dependent manner," Journal of Biological Chemistry, vol. 277, no. 36, pp. 32791-32798, 2002.
62. S. Fujii, S. Mitsunaga, M. Yamazaki et al., "Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome," Cancer Science, vol. 99, no. 9, pp. 1813-1819, 2008.
63. D. G. DeNardo, M. Johansson, and L. M. Coussens, "Inflaming gastrointestinal oncogenic programming," Cancer Cell, vol. 14, no. 1, pp. 7-9, 2008.
64. R. Abe and S. Yamagishi, "AGE-RAGE systemand carcinogenesis," Current Pharmaceutical Design, vol. 14, no. 10, pp. 940-945, 2008.
65. T. Arumugam, D. M. Simeone, K. Van Golen, and C. D. Logsdon, "S100P promotes pancreatic cancer growth, survival, and invasion," Clinical Cancer Research, vol. 11, no. 15, pp. 5356-5364, 2005.
66. R. Kang, D. Tang, N. E. Schapiro et al., "The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival," Cell Death and Differentiation, vol. 17, no. 4, pp. 666-676, 2010.
67. R. J. Kewley, M. L. Whitelaw, and A. Chapman-Smith, "The mammalian basic helix-loop-helix/PAS family of transcriptional regulators," The International Journal of Biochemistry & Cell Biology, vol. 36, no. 2, pp. 189-204, 2004.
68. M. B. Azad, Y. Chen, E. S. Henson et al., "Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3," Autophagy, vol. 4, no. 2, pp. 195-204, 2008.
69. T. R. Burton and S. B. Gibson, "The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death," Cell Death and Differentiation, vol. 16, no. 4, pp. 515-523, 2009.
70. J. Okami, D. M. Simeone, and C. D. Logsdon, "Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer," Cancer Research, vol. 64, no. 15, pp. 5338-5346, 2004.
71. P. C. Mahon, P. Baril, V. Bhakta et al., "S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer," Cancer Research, vol. 67, no. 14, pp. 6786-6795, 2007.
72. T. Abe, M. Toyota, H. Suzuki et al., "Upregulation of BNIP3 by 5-aza-2′-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death," Journal of Gastroenterology, vol. 40, no. 5, pp. 504-510, 2005.
73. J. Guan, P. E. Stromhaug, M. D. George et al., "Cvt18/Gsa12 is required for cytoplasm-to-vacuole transport, pexophagy, and autophagy in Saccharomyces cerevisiae and Pichia pastoris," Molecular Biology of the Cell, vol. 12, no. 12, pp. 3821-3838, 2001.
74. T. Proikas-Cezanne, S. Waddell, A. Gaugel, T. Frickey, A. Lupas, and A. Nordheim, "WIPI-1α (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy," Oncogene, vol. 23, no. 58, pp. 9314-9325, 2004.
75. O. Warburg, "On the origin of cancer cells," Science, vol. 123, no. 3191, pp. 309-314, 1956.
76. D. Nelson and D. Cox, Lehninger Principles of Biochemistry, chapter 14, WH Freeman and Co., New York, NY, USA, 2008.
77. R. Bartrons and J. Caro, "Hypoxia, glucose metabolism and the Warburg's effect," Journal of Bioenergetics and Biomembranes, vol. 39, no. 3, pp. 223-229, 2007.
78. V. Gogvadze, B. Zhivotovsky, and S. Orrenius, "The Warburg effect and mitochondrial stability in cancer cells," Molecular Aspects of Medicine, vol. 31, no. 1, pp. 60-74, 2010.
79. M. Vincent, "Cancer: a de-repression of a default survival program common to all cells?" BioEssays, vol. 34, no. 1, pp. 72-82, 2012.
80. S. J. Bensinger and H. R. Christofk, "New aspects of the Warburg effect in cancer cell biology," Seminars in Cell and Developmental Biology, vol. 23, no. 4, pp. 352-361, 2012.
81. K. Bensaad, A. Tsuruta, M. A. Selak et al., "TIGAR, a p53-inducible regulator of glycolysis and apoptosis," Cell, vol. 126, no. 1, pp. 107-120, 2006.
82. L. M. Nilsson, T. Z. Plym Forshell, S. Rimpi et al., "Mouse genetics suggests cell-context dependency for myc-regulated metabolic enzymes during tumorigenesis," PLoS Genetics, vol. 8, no. 3, Article ID e1002573, 2012.
83. U. E. Martinez-Outschoorn, S. Pavlides, D. Whitaker-Menezes et al., "Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors," Cell Cycle, vol. 9, no. 12, pp. 2423-2433, 2010.
84. M. P. Lisanti, U. E. Martinez-Outschoorn, B. Chiavarina et al., "Understanding the "lethal" drivers of tumor-stroma coevolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment," Cancer Biology and Therapy, vol. 10, no. 6, pp. 537-542, 2010.
85. T. Smith-Vikos, "A report of the James Watson lecture at Yale University," The Yale Journal of Biology and Medicine, vol. 85, no. 3, pp. 417-419, 2012.
86. S. del Barco, A. Vazquez-Martin, S. Cufí et al., "Metformin: multi-faceted protection against cancer," Oncotarget, vol. 2, no. 12, pp. 896-917, 2011.
87. B. Chiavarina, D. Whitaker-Menezes, U. E. Martinez-Outschoorn et al., "Pyruvate kinase expression (PKM1 and PKM2) in cancer associated fibroblasts drives stromal nutrient production and tumor growth," Cancer Biology and Therapy, vol. 12,no. 12, pp. 1101-1113, 2011.
88. +-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells," Cell Cycle, vol. 12, no. 2, pp. 207-218, 2013.
89. V. Rausch, L. Liu, A. Apel et al., "Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment," The Journal of Pathology, vol. 227, no. 3,pp. 325-335, 2012.
90. R. K. Amaravadi, J. Lippincott-Schwartz, X. Yin et al., "Principles and current strategies for targeting autophagy for cancer treatment," Clinical Cancer Research, vol. 17, no. 4, pp. 654-666, 2011.
91. J. Choi, H. Kim do, W. H. Jung, and J. S. Koo, "Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype," Breast Cancer Research, vol. 15, no. 5, article R78, 2013.
92. J. D. Mancias and A. C. Kimmelman, "Targeting autophagy addiction in cancer," Oncotarget, vol. 2, no. 12, pp. 1302-1306, 2011.
93. B. Ewald, D. Sampath, and W. Plunkett, "Nucleoside analogs: molecular mechanisms signaling cell death," Oncogene, vol. 27, no. 50, pp. 6522-6537, 2008.
94. I. Vivanco and C. L. Sawyers, "The phosphatidylinositol 3-kinase-AKT pathway in human cancer," Nature Reviews Cancer, vol. 2, no. 7, pp. 489-501, 2002.
95. A. S. N. Jackson, P. Jain, G. R. Watkins et al., "Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in local advanced pancreatic cancer," Clinical Oncology, vol. 22, no. 7, pp. 570-577, 2010.
96. R. Sheikh, N. Walsh, M. Clynes, R. O'connor, and R. McDermott, "Challenges of drug resistance in the management of pancreatic cancer," Expert Review of Anticancer Therapy, vol. 10, no. 10, pp. 1647-1661, 2010.
97. T. Conroy, F. Desseigne, M. Ychoy et al., "Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial," Journal of Clinical Oncology, vol. 28, supplement 15s, abstract 4010, 2010.
98. W. Tung, Y. Wang, P. W. Gout, D. M. Liu, and M. Gleave, "Use of irinotecan for treatment of small cell carcinoma of the prostate," Prostate, vol. 71, no. 7, pp. 675-681, 2011.
99. M. I. Vaccaro, C. D. Gonzalez, S. Alvarez, and A. Ropolo, "Modulating autophagy and the 'reverse warburg effect'," in Tumor Metabolome Targeting and Drug Development, Cancer Drug Discovery and Development, S. Kanner, Ed., Springer, New York, NY, USA, 2014.